These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 52967)

  • 1. Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasis.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson J-A ; Jacobsson S; Rorsman H; Rosengrem A-M ; Rosengren E
    Acta Derm Venereol; 1975; 55(5):337-41. PubMed ID: 52967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-S-cysteinyldopa in the urine of melanoma patients.
    Agrup G; Agrup P; Andersson T; Falck B; Hansson JA; Jacobsson S; Rorsman H; Rosengren E; Rosengren AM
    Acta Derm Venereol; 1977; 57(2):113-6. PubMed ID: 71802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
    Agrup G; Agrup P; Andersson T; Hafström L; Hansson C; Jacobsson S; Jönsson PE; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1979; 59(5):381-8. PubMed ID: 93360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [5-S-cysteinyldopa in the urine - a "tumor test" for malignant melanoma? Comparison with the usual laboratory examinations].
    Paul E; Graef V; Ruppel R
    Z Hautkr; 1980 Dec; 55(23):1543-60. PubMed ID: 6782780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [5-S-cysteinyldopa determination in the urine. Its value for monitoring in melanoma patients].
    Paul E; Graef V; Ruppel R; Hellwich M
    Z Hautkr; 1983 Feb; 58(4):262-5. PubMed ID: 6405551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM; Miller S; Gunder M
    Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-S-cysteinyldopa in the plasma of melanoma patients and the renal clearance of this amino acid.
    Agrup G; Andersson T; Falck B; Persson K; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1975; 55(1):5-6. PubMed ID: 46673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.
    Morishima T; Tatsumi F; Fukada E; Saito M; Fujita M; Nagashima N; Hanawa S
    Arch Dermatol Res; 1983; 275(2):76-9. PubMed ID: 6409012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary 5-S-cysteinyldopa levels in patients with malignant melanoma. Preliminary results].
    Césarini JP; Meunier M
    Rev Prat; 1975 Nov; 25(51):4037-9. PubMed ID: 1209143
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urinary 5-S-cysteinyldopa in malignant melanoma subjects-with special reference to melanoma stages and dopa loading test (author's transl)].
    Ichihasi M; Mojamdar M; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1981 Sep; 91(10):1045-9. PubMed ID: 6798247
    [No Abstract]   [Full Text] [Related]  

  • 11. Demonstration of 3-methoxytyrosine in the urine of melanoma patients.
    Agrup G; Bengtsson M; Falck B; Persson K; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1976; 56(1):27-31. PubMed ID: 56853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine excretion of 5-S-cysteinyldopa and serum sialic acid as tumor markers in human melanomas.
    Marnot D; Decaux F; Berthelot P; Kalis B; Jardillier JC; Warren L
    Cancer Detect Prev; 1983; 6(1-2):303-10. PubMed ID: 6411338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases.
    Yamada K; Walsh N; Hara H; Jimbow K; Chen H; Ito S
    Arch Dermatol; 1992 Apr; 128(4):491-4. PubMed ID: 1580656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative studies between excretion of 5-S-cysteinyldopa and indole melanogens in urine].
    Beyer C; Fiedler H; Wohlrab W; Wozniak KD
    Dermatol Monatsschr; 1986; 172(9):541-4. PubMed ID: 3098590
    [No Abstract]   [Full Text] [Related]  

  • 15. Melanin-related metabolites in urine of B16 melanoma-bearing mice.
    Wakamatsu K; Ito S; Fujita K
    Acta Derm Venereol; 1988; 68(5):385-9. PubMed ID: 2461020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urinary melanogen cysteinyldopa in melanoma and in suntanning: Australian experience.
    Nixon PF
    Aust N Z J Surg; 1978 Feb; 48(1):17-21. PubMed ID: 276342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal variation in urinary excretion of 5-S-cysteinyldopa in healthy Japanese.
    Ito S; Kato T; Fujita K
    Acta Derm Venereol; 1987; 67(2):163-5. PubMed ID: 2438883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Melanoma metabolites (proceedings)].
    Rorsman H
    Lakartidningen; 1978 Dec; 75(49):4596-7. PubMed ID: 723347
    [No Abstract]   [Full Text] [Related]  

  • 19. [Correlation of urinary 5-S-cysteinyldopa with repeated remission of melanoma induced by DTIC combination chemotherapy].
    Inoi T; Mojamdar M; Ichihashi M; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1982 Sep; 92(10):1065-9. PubMed ID: 6821170
    [No Abstract]   [Full Text] [Related]  

  • 20. Trichochromuria in melanosis of melanoma.
    Rorsman H; Agrup P; Carlén B; Hansson C; Jonsson N; Rosengren E; Tegner E
    Acta Derm Venereol; 1986; 66(6):468-73. PubMed ID: 2433864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.